Metabolic Cancer Treatment Research Entrectinib: A new TKI for ROS1+ NSCLC with brain mets by Maggie Jones July 11, 2019 by Maggie Jones July 11, 2019 I’m embarrassed that I’ve had this article open in my browser for months and haven’t written about it. Good news for ROS1nders! Entrectinib is getting close to FDA approval. While… 1 FacebookTwitterPinterestRedditEmail
